|
University of California, Irvine |
Henry Klassen |
Disease Team Planning |
Stem cells for neuroprotection of photoreceptors in retinitis pigmentosa |
$37,367 |
|
Buck Institute for Age Research |
Mary McEachron |
Major Facilities |
No Title |
$20,500,000 |
|
Ludwig Institute for Cancer Research |
Webster Cavenee |
Disease Team Planning |
Stem Cell-Mediated Oncocidal Therapy of Primary & Metastatic Brain Tumors |
$55,000 |
|
Sanford Consortium for Regenerative Medicine |
Edward Holmes |
Major Facilities |
No Title |
$43,000,000 |
|
Children's Hospital of Oakland Research Institute |
Mark Walters |
Disease Team Planning |
CIRM Disease Team Planning Award |
$55,000 |
|
Stanford University |
John Hennessy |
Major Facilities |
No Title |
$43,578,000 |
|
ViaCyte, Inc. |
Howard Foyt |
Strategic Partnership I |
Preclinical and clinical testing of a stem cell-based combination product for insulin-dependent diabetes |
$10,075,070 |
|
Cedars-Sinai Medical Center |
Eduardo Marbán |
Disease Team Planning |
{REDACTED} Heart Disease Regenerative Medicine Team Planning Award |
$46,886 |
|
University of California, Berkeley |
George Breslauer |
Major Facilities |
No Title |
$20,183,500 |
|
Bluebird Bio |
David Davidson |
Strategic Partnership I |
A Phase 1/2, Open Label Study Evaluating the Safety and Efficacy of Gene Therapy in Subjects with β-Thalassemia by Transplantation of Autologous Hematopoietic Stem Cells [REDACTED] |
$9,363,335 |
|
University of California, Irvine |
Leslie Thompson |
Disease Team Planning |
Huntington's Disease Team |
$54,618 |
|
University of California, Davis |
Larry Vanderhoef |
Major Facilities |
No Title |
$20,082,400 |
|
Children's Hospital of Los Angeles |
Donald Kohn |
Disease Team Planning |
STEM CELL GENE THERAPY FOR SICKLE CELL DISEASE |
$33,110 |
|
University of California, Irvine |
Michael Drake |
Major Facilities |
No Title |
$27,156,000 |
|
Sanford-Burnham Medical Research Institute |
Mark Mercola |
Disease Team Planning |
"Stem Cell Therapies for Heart Failure" |
$53,150 |
|
University of California, Los Angeles |
Gene Block |
Major Facilities |
No Title |
$19,854,900 |
|
Beckman Research Institute of City of Hope |
Michael Barish |
Disease Team Planning |
Genetically-modified neural stem cells for treatment of high-grade glioma |
$55,000 |
|
University of California, Merced |
John White |
Major Facilities |
No Title |
$4,359,480 |
|
University of California, San Diego |
Mana Parast |
New Faculty Physician Scientist |
Human pluripotent stem cell-based therapeutics for preeclampsia |
$3,013,252 |
|
University of California, Los Angeles |
Yi Sun |
Basic Biology III |
Studying neurotransmission of normal and diseased human ES cell-derived neurons in vivo |
$1,382,400 |
|
Berkeley City College |
Barbara Des Rochers |
Bridges |
Specialty in Stem Cell Biology |
$2,450,257 |
|
Beckman Research Institute of City of Hope |
Paul Salvaterra |
Creativity Awards |
Creativity Award Program in Stem Cell Biology for California High School Students |
$211,200 |
|
OncoMed Pharmaceuticals, Inc. |
Timothy Hoey |
Disease Team Therapy Planning I |
[REDACTED]: A New Cancer Therapeutic to Reduce CSC Frequency |
$65,120 |
|
University of California, San Francisco |
Holger Willenbring |
Early Translational III |
Generation of safe and therapeutically effective human induced hepatocyte-like cells |
$1,544,170 |
|
Stanford University |
Michelle Monje |
New Faculty Physician Scientist |
White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain” |
$2,800,536 |
|
The J. David Gladstone Institutes |
Deepak Srivastava |
Basic Biology III |
Mechanisms of Direct Cardiac Reprogramming |
$1,708,560 |
|
Scripps Research Institute |
James Williamson |
Creativity Awards |
Stem Cell Summer Academy: Creating the Next Generation of Scientists |
$206,250 |
|
University of California, Davis |
Nancy Lane |
Disease Team Therapy Planning I |
Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis |
$110,000 |
|
University of California, Berkeley |
Zhigang He |
Research Leadership 7 |
Developing a regeneration-based functional restoration treatment for spinal cord injury |
$5,609,890 |
|
The J. David Gladstone Institutes |
Deepak Srivastava |
Early Translational III |
Direct Cardiac Reprogramming for Heart Regeneration |
$6,319,110 |
|
University of California, San Francisco |
Tippi MacKenzie |
New Faculty Physician Scientist |
In Utero Embryonic Stem Cell Transplantation to Treat Congenital Anomalies |
$2,661,742 |
|
University of California, San Francisco |
Katherine Nielsen |
Creativity Awards |
[REDACTED] SEP High School Intern Program |
$143,550 |
|
Cedars-Sinai Medical Center |
Dan Gazit |
Disease Team Therapy Planning I |
Genetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures. |
$109,743 |
|
Stanford University |
Helen Blau |
Early Translational III |
Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients |
$1,825,920 |
|
Cedars-Sinai Medical Center |
Robert Baloh |
New Faculty Physician Scientist |
Human iPSC modeling and therapeutics for degenerative peripheral nerve disease |
$3,031,737 |
|
Stanford University |
Sean Wu |
Basic Biology III |
Elucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells |
$1,425,600 |
|
Stanford University |
Michael Longaker |
Traning Grant I-1 |
Stanford CIRM Training Program |
$3,733,707 |
|
Geron Corporation |
Jane Lebkowski |
Targeted Clinical Development |
Evaluation of Safety and Preliminary Efficacy of Escalating Doses of GRNOPC1 in Subacute Spinal Cord Injury |
$24,846,856 |
|
Cedars-Sinai Medical Center |
Clive Svendsen |
Disease Team Therapy Planning I |
Stem Cells Secreting GDNF for the Treatment of ALS |
$89,834 |
|
University of California, San Diego |
Mark Tuszynski |
Early Translational III |
Functional Neural Relay Formation by Human Neural Stem Cell Grafting in Spinal Cord Injury |
$4,699,569 |
|
University of California, San Diego |
Deborah Spector |
Basic Biology III |
Viral-host interactions affecting neural differentiation of human progenitors |
$1,372,660 |
|
University of California, San Francisco |
Susan Fisher |
Traning Grant I-1 |
Training Grant I |
$3,620,652 |
|
Beckman Research Institute of City of Hope |
Jiing-Kuan Yee |
Basic Biology III |
Use of human iPS cells to study spinal muscular atrophy |
$1,268,868 |
|
Stanford University |
Robert Robbins |
Disease Team Therapy Planning I |
Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure |
$108,895 |
|
Stanford University |
Renee Reijo Pera |
Early Translational III |
Autologous iPSC Therapy for Urinary Incontinence |
$5,279,607 |
|
The Parkinson's Institute |
R. Jeremy Nichols |
Basic Biology III |
Understanding the role of LRRK2 in iPSC cell models of Parkinson's Disease |
$1,482,822 |
|
University of California, Berkeley |
Song Li |
Basic Biology III |
Induced Pluripotent Stem Cells for Tissue Regeneration |
$1,341,064 |
|
University of California, Davis |
Vicki Wheelock |
Disease Team Therapy Planning I |
MSC engineered to produce BDNF for the treatment of Huntington's disease |
$99,248 |
|
University of California, San Diego |
Yang Xu |
Early Translational III |
Human ES cell based therapy of heart failure without allogenic immune rejection |
$1,857,600 |
|
Stanford University |
Renee Reijo Pera |
Basic Biology III |
Correlated time-lapse imaging and single cell molecular analysis of human embryo development |
$1,425,600 |
|
University of Southern California |
Robert Maxson |
Traning Grant I-1 |
CIRM Stem Cell Biology Training Grant |
$3,158,532 |
|
University of California, Los Angeles |
Ali Nsair |
Basic Biology III |
Characterization and Engineering of the Cardiac Stem Cell Niche |
$1,181,306 |
|
StemCells, Inc. |
Alexandra Capela |
Disease Team Therapy Planning I |
Neuroprotection to treat Alzheimer's: a new paradigm using human central nervous system cells |
$98,050 |
|
California Polytechnic State University, San Luis Obispo |
Trevor Cardinal |
Bridges |
Masters of Science Specialization in Stem Cell Technology |
$3,020,182 |
|
University of California, San Diego |
Eugene Yeo |
Early Translational III |
Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons |
$1,654,830 |
|
Stanford University |
Michael Clarke |
Basic Biology III |
USP16 controls stem cell number: implications for Down Syndrome |
$1,425,600 |
|
University of California, Los Angeles |
Owen Witte |
Traning Grant I-1 |
CIRM Type I Comprehensive Training Program |
$3,750,000 |
|
University of California, San Diego |
Anirvan Ghosh |
Basic Biology III |
Investigation of synaptic defects in autism using patient-derived induced pluripotent stem cells |
$1,391,400 |
|
University of California, Los Angeles |
Stanley Nelson |
Disease Team Therapy Planning I |
Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy |
$86,414 |
|
California State Polytechnic University, Pomona |
Jill Adler-Moore |
Bridges |
Collaborative CIRM Bridges Program to Enhance Stem Cell Research Training and Education |
$3,008,975 |
|
University of California, San Francisco |
Arnold Kriegstein |
Early Translational III |
Human ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury |
$1,623,251 |
|
Stanford University |
Joanna Wysocka |
Basic Biology III |
Enhancer-mediated gene regulation during early human embryonic development |
$1,425,600 |
|
University of California, Davis |
Frederick Meyers |
Traning Grant I-1 |
Stem Cell Research Training Grant |
$2,682,900 |
|
Scripps Research Institute |
Joel Gottesfeld |
Basic Biology III |
Triplet Repeat Instability in Human iPSCs |
$1,755,861 |
|
Sanford-Burnham Medical Research Institute |
Marcel Daadi |
Disease Team Therapy Planning I |
Neural Stem Cell-Based Therapy For Parkinson’s Disease |
$99,976 |
|
California State University, Channel Islands |
Ching-Hua Wang |
Bridges |
Curriculum Development and Implementation of Stem Cell Technology and Laboratory Management Emphasis in an Established MS Biotechnology and Bioinformatics Program at (REDACTED) and Co-development of a GE Course on Stem Cel |
$3,614,553 |
|
University of California, San Diego |
Lawrence Goldstein |
Early Translational III |
Identifying Drugs for Alzheimer's Disease with Human Neurons Made From Human IPS cells |
$1,857,600 |
|
University of California, Los Angeles |
Kathrin Plath |
Basic Biology III |
Discovery of mechanisms that control epigenetic states in human reprogramming and pluripotent cells |
$1,364,598 |
|
University of California, Berkeley |
Randy Schekman |
Traning Grant I-1 |
Human Stem Cell Training at UC Berkeley and Childrens Hospital of Oakland |
$2,529,810 |
|
University of California, Los Angeles |
William Lowry |
Basic Biology III |
Molecular determinants of accurate differentiation from human pluripotent stem cells |
$1,354,230 |
|
California State University, Fullerton |
Nilay Patel |
Bridges |
Stem Cell Training Program - A Bridge to Stem Cell Research |
$2,710,703 |
|
The Salk Institute for Biological Studies |
Juan Carlos Izpisua Belmonte |
Early Translational III |
Direct reprogramming towards vascular progenitors for the treatment of ischemia |
$2,340,000 |
|
University of California, San Francisco |
Harold Bernstein |
Basic Biology III |
Phenotypic Analysis of Human ES Cell-Derived Muscle Stem Cells |
$1,381,296 |
|
University of California, Irvine |
Peter Bryant |
Traning Grant I-1 |
Stem Cell Research Training Grant |
$2,039,845 |
|
University of California, Los Angeles |
Shuo Lin |
Basic Biology III |
Etsrp/ER71 mediated stem cell differentiation into vascular lineage |
$1,382,400 |
|
California State University, Long Beach |
Lisa Klig |
Bridges |
CIRM Stem Cell Research Biotechnology Training Program |
$3,042,698 |
|
The Salk Institute for Biological Studies |
David Schubert |
Early Translational III |
Stem cell based small molecule therapy for Alzheimer's disease |
$1,673,757 |
|
Scripps Research Institute |
Peter Schultz |
Traning Grant I-2 |
Training Grant I |
$1,059,300 |
|
Children's Hospital of Los Angeles |
Tracy Grikscheit |
New Faculty Physician Scientist |
The generation and expansion of tissue-engineered small intestine from human stem/ progenitor cells: a preclinical study of functional translation |
$3,408,000 |
|
Scripps Research Institute |
Kristin Baldwin |
Basic Biology III |
Identifying sources of mutation in human induced pluripotent stem cells by whole genome sequencing |
$1,755,864 |
|
California State University, Northridge |
Cindy Malone |
Bridges |
Bridges to Stem Cell Research |
$3,382,877 |
|
University of California, Davis |
John Laird |
Disease Team Therapy Planning I |
Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia |
$76,861 |
|
The J. David Gladstone Institutes |
Robert Mahley |
Traning Grant I-2 |
Gladstone CIRM Scholar Program |
$2,397,240 |
|
University of California, San Francisco |
Ophir Klein |
New Faculty Physician Scientist |
Stem cell therapy for inflammatory bowel disease |
$3,084,000 |
|
University of California, San Francisco |
John Murnane |
Basic Biology III |
Genomic instability during culturing of human embryonic stem cells |
$1,074,355 |
|
California State University, Sacramento |
Jane Bruner |
Bridges |
Strengthening the Pipeline of Masters-level Scientific and Laboratory Personnel in Stem Cell Research |
$2,773,463 |
|
University of California, Davis |
Mehrdad Abedi |
Disease Team Therapy Planning I |
RUNNING TITLE: Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients |
$74,195 |
|
University of California, San Francisco |
Jason Pomerantz |
New Faculty Physician Scientist |
Characterization of Human Skeletal Muscle Stem Cells for Clinical Application |
$3,084,000 |
|
University of California, Berkeley |
Michael Rape |
Basic Biology III |
Ubiquitin-dependent control of hESC self-renewal and expansion |
$1,364,091 |
|
California State University, San Bernardino |
Nicole Bournias-Vardiabasis |
Bridges |
Bridges to Stem Cell Research |
$2,607,705 |
|
Cedars-Sinai Medical Center |
Clive Svendsen |
iPSC Consortia Award |
The HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development |
$300,000 |
|
Stanford University |
Judith Shizuru |
Disease Team Therapy Planning I |
A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants |
$109,676 |
|
University of California, Los Angeles |
Donald Kohn |
Traning Grant I-2 |
Training Grant 1 |
$2,390,826 |
|
University of California, San Francisco |
Ann Zovein |
New Faculty Physician Scientist |
Human endothelial reprogramming for hematopoietic stem cell therapy. |
$3,084,000 |
|
Beckman Research Institute of City of Hope |
Stephen Forman |
Early Translational III |
Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells |
$5,217,004 |
|
California State University, San Marcos |
Bianca Mothe |
Bridges |
CIRM Bridges to the Stem Cell Research Training Grant |
$3,613,311 |
|
University of California, Santa Barbara |
Carol Pasternack |
Creativity Awards |
Research Mentorship Program-Immersing High School Students in College Research |
$223,080 |
|
University of California, Davis |
Martin Birchall |
Disease Team Therapy Planning I |
Airways for Children |
$71,248 |
|
California Institute of Technology |
Paul Patterson |
Traning Grant I-2 |
Training in Stem Cell Biology at CIT |
$2,318,580 |
|
University of California, Los Angeles |
Reza Ardehali |
New Faculty Physician Scientist |
Preclinical evaluation of human embryonic stem cell-derived cardiovascular progenitors |
$2,930,388 |